TABLE 1. Maintenance treatment studies for unipolar disorder

 

 

 

Length of

 

 

 

 

Symptom-free

study

 

 

 

Study

interval

(yr)

Treatment

Total N

Outcomea

Bjork et al. (11)

4 months

1

Zimelidine

Placebo

38

Z > P

Coppen et al. (15)

6 months

1

Amitriptyline

Placebo

29

A > P

Coppen et al. (16)

Undefined b

2

Lithium

Placebo

26

L > P

Doogan et al. (18)

Undefined

1

Sertraline

Placebo

295

S > P

Eric et al. (20)

Undefined

1

Paroxetine

Placebo

125

Pa > P

Frank et al. (23)

17 weeks

3

Imipramine

Placebo

51

I > P

Georgotis et al. (27)

4 months

1

Phenelzine

Nortriptyline

Placebo

51

Ph > P

Ph > N

N = P

Glen et al. (28)

Undefined

3

Lithium

Amitriptyline

Placebo

28

L = A = P

Kane et al. (37)

6 months

2

Lithium

Imipramine

Placebo

19

L > P

L > I

I  = P

Montgomery et  al. (49)

18 weeks

1

Fluoxetine

Placebo

220

F > P

 

OADIG (53)

8 weeks

2

Diothepin

Placebo

69

D > P

 

Prien et al. (60)

Undefined b

2

Lithium

Imipramine

Placebo

88

L > P

I > P

L = I

Prien et al. (62)

2 months

2

Lithium

Imipramine

Placebo

110

L > P

I > P

L > I

Robinson et al. (65)

16 weeks

2

Phenelzine

Placebo

47

Ph > P

Rouillan et al. (67)

Undefined

1

Maprotiline

Placebo

 

1141

M > P

 

   a Based on p = 0.05 level of significance.

   b Maintenance treatment initiated at discharge from hospital.

 

Back to Chapter

 

published 2000